BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laryngoscope
,
Phenobarbital
,
rs2476601
,
CYP51
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
2 deoxycytidine 5'- triphosphate
Summary
General Info
Curated Studies
Most Correlated Studies
MCF7 cells gene expression after 72hr treatment with 5-Aza-CdR or DZNep
Explore Curated Studies Results
Literature
Most Relevant Literature
DCTPP1 prevents a mutator phenotype through the modulation of dCTP, dTTP and dUTP pools.
The NTP pyrophosphatase DCTPP1 contributes to the homoeostasis and cleansing of the dNTP pool in hum…
Simultaneous determination of deoxycytidine diphosphate and deoxycytidine triphosphate by capillary …
Bacillus halodurans Strain C125 Encodes and Synthesizes Enzymes from Both Known Pathways To Form dUM…
Mutational consequences of dNTP pool imbalances in E. coli.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Be…
Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome
FdCyd and THU for Advanced Solid Tumors
3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Remo…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ